关注
Curtis Triplitt
Curtis Triplitt
University of Texas Health Science Center at San Antonio
在 uthscsa.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
WHO benchmarks for International Health Regulations (IHR) capacities
World Health Organization
World Health Organization, 2019
3333*2019
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
Y Miyazaki, L Glass, C Triplitt, M Matsuda, K Cusi, A Mahankali, ...
Diabetologia 44, 2210-2219, 2001
3812001
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
Y Miyazaki, L Glass, C Triplitt, E Wajcberg, LJ Mandarino, RA DeFronzo
American Journal of Physiology-Endocrinology and Metabolism 283 (6), E1135-E1143, 2002
3442002
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E …
MA Abdul‐Ghani, C Puckett, C Triplitt, D Maggs, J Adams, E Cersosimo, ...
Diabetes, Obesity and Metabolism 17 (3), 268-275, 2015
2282015
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
A Cervera, E Wajcberg, A Sriwijitkamol, M Fernandez, P Zuo, C Triplitt, ...
American Journal of Physiology-Endocrinology and Metabolism 294 (5), E846-E852, 2008
2052008
Pathogenesis of type 2 diabetes mellitus
E Cersosimo, C Triplitt, C Solis-Herrera, LJ Mandarino, RA DeFronzo
Endotext, 12-16, 2000
1602000
Rosiglitazone decreases albuminuria in type 2 diabetic patients
Y Miyazaki, E Cersosimo, C Triplitt, RA DeFronzo
Kidney international 72 (11), 1367-1373, 2007
1512007
Drug interactions of medications commonly used in diabetes
C Triplitt
Diabetes Spectrum 19 (4), 202, 2006
1482006
Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate
JE Galgani, LK Heilbronn, K Azuma, DE Kelley, JB Albu, X Pi-Sunyer, ...
Diabetes 57 (4), 841-845, 2008
1442008
Understanding the kidneys' role in blood glucose regulation
CL Triplitt
American Journal of Managed Care 18 (1), S11, 2012
1412012
Effects of exenatide plus rosiglitazone on β-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin
RA DeFronzo, C Triplitt, Y Qu, MS Lewis, D Maggs, LC Glass
Diabetes care 33 (5), 951-957, 2010
1342010
Examining the mechanisms of glucose regulation
CL Triplitt
American Journal of Managed Care 18 (1), S4, 2012
1152012
Classification of diabetes mellitus
C Solis-Herrera, C Triplitt, C Reasner, RA DeFronzo, E Cersosimo
1082015
Novel agents for the treatment of type 2 diabetes
RA DeFronzo, CL Triplitt, M Abdul-Ghani, E Cersosimo
Diabetes Spectrum 27 (2), 100-112, 2014
1032014
Exenatide improves both hepatic and adipose tissue insulin resistance: a dynamic positron emission tomography study
A Gastaldelli, M Gaggini, G Daniele, D Ciociaro, E Cersosimo, D Tripathy, ...
Hepatology 64 (6), 2028-2037, 2016
982016
Physiological and molecular determinants of insulin action in the baboon
AO Chavez, JC Lopez-Alvarenga, ME Tejero, C Triplitt, RA Bastarrachea, ...
Diabetes 57 (4), 899-908, 2008
902008
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
H Al Jobori, G Daniele, J Adams, E Cersosimo, C Solis-Herrera, C Triplitt, ...
The Journal of Clinical Endocrinology & Metabolism 103 (4), 1402-1407, 2018
892018
Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients
H Al Jobori, G Daniele, J Adams, E Cersosimo, C Triplitt, RA DeFronzo, ...
Diabetes, Obesity and Metabolism 19 (6), 809-813, 2017
832017
Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study
C Solis-Herrera, C Triplitt, JJ Garduno-Garcia, J Adams, RA DeFronzo, ...
Diabetes care 36 (9), 2756-2762, 2013
792013
New technologies and therapies in the management of diabetes
CL Triplitt
Am J Manag Care 13 (Suppl 2), S47-54, 2007
772007
系统目前无法执行此操作,请稍后再试。
文章 1–20